LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN STANLEY | 122 | $403 | 0.00% |
| BlackRock Inc. | 43,460 | $143,418 | 0.00% |
| Bank of New York Mellon Corp | 11,858 | $39,130 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 11,445 | $37,769 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,932 | $6,376 | 0.00% |
| Qube Research & Technologies Ltd | 3 | $10 | 0.00% |
| Global Retirement Partners, LLC | 11 | $46 | 0.00% |
| Iron Horse Wealth Management, LLC | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 35 | $116 | 0.00% |
| ROYAL BANK OF CANADA | 117 | $0 | 0.00% |
| VANGUARD GROUP INC | 235,437 | $776,942 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 41 | $135 | 0.00% |
| Cypress Capital Management LLC (WY) | 100 | $330 | 0.00% |
| Live Oak Investment Partners | 11 | $36 | 0.00% |
| OSAIC HOLDINGS, INC. | 7,652 | $25,248 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 15,564 | $51,393 | 0.00% |
External links
This page lists LUMOS PHARMA INC's shareholders in Q3 2023. To view LUMOS PHARMA INC's shareholder history, click here.